Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to ...

Medtronic (MDT) is reportedly looking at adjusting its global manufacturing footprint amid heightened concerns that the U.S.

But thermodynamics are completely different in an isochoric system, where volume remains constant and pressure changes.” In ...

ViCentra announced today that it appointed Tom Arnold as its new CEO to accelerate growth with the Kaleido automated insulin ...

The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...

The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in ...

The latest health news reveals Medtronic's strategic response to U.S. tariffs, WHO's concerns on West Bank violence, mystery ...

In a welcome move, Medtronic stock saw its Relative Strength Rating improve from 67 to 73 on Tuesday. Please watch the video ...

The FDA has approved Medtronic's Brainsense Adaptive deep brain stimulation for patients with Parkinson's disease. The technology is designed to adjust therapy in real time based on a patient's brain ...

AIG’s Dr. Nageshwar Reddy stresses the need for India-specific data to improve AI accuracy in diagnostics and patient care ...

As some 400 folks filled the Jim Rouse Center at the American Visionary Art Museum to help the Casey Cares Foundation ...

Experienced MedTech leader to scale manufacturing, drive European expansion, and position the company to enter the US market with the Kaleido insulin patch pump AID systemUTRECHT, The Netherlands ...